Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_assertion type Assertion NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_head.
- NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_assertion description "[The positive predictive value for type 2 HHT (ACVRL1 positive) patients to develop liver disease until the age of 52 years is 68.4%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_provenance.
- NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_assertion evidence source_evidence_literature NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_provenance.
- NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_assertion SIO_000772 18498373 NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_provenance.
- NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_assertion wasDerivedFrom befree-20140225 NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_provenance.
- NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_assertion wasGeneratedBy ECO_0000203 NP511549.RAaYGJC8Tnb9TLZqZBYg6Lrf386G9zqx5FdLJr_0VAwrY130_provenance.